These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5784806)

  • 21. Clinical trial of compound 1029 (vatensol).
    Srivastava BN; Gupta RK; Harshvardhan ; Goswami SL
    Indian Heart J; 1966 Oct; 18(4):333-44. PubMed ID: 5977540
    [No Abstract]   [Full Text] [Related]  

  • 22. [The broad-spectrum antihypertensive agent Tadip in slight and moderate hypertension].
    Kempf E
    Med Monatsschr; 1968 Jun; 22(6):270-5. PubMed ID: 5720912
    [No Abstract]   [Full Text] [Related]  

  • 23. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

  • 24. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
    Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G
    Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guancydine. Clinical evaluation of a new hypotensive agent].
    da Silva JA; Antunes NM; Laraia Cde B; Fraga Filho C
    Rev Bras Med; 1972 Jan; 29(1):42-7. PubMed ID: 5017517
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antihypertensive effectiveness of a guanfacine/clopamide combination].
    Wetzels E; Weidinger G
    MMW Munch Med Wochenschr; 1982 Oct; 124(40):871-4. PubMed ID: 6815503
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antihypertensive activity of a new molecule, 2,6-dichloro-benzylidene aminoguanidine acetate].
    Chiummo R
    Minerva Med; 1975 Dec; 66(84):4546-50. PubMed ID: 1202408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO].
    Mayer K; Lupínek Z; Janousek S; Podrouzková B
    Cas Lek Cesk; 1984 Oct; 123(43):1306-11. PubMed ID: 6391673
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy of hypertension with Leron (cyclacenin) and Tadip (cyclacenin and alpha-methyldopa)].
    Stampfer E
    Wien Med Wochenschr; 1968 Jun; 118(24):551-4. PubMed ID: 5711781
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experiences with a new antihypertensive agent (Tadip)].
    Becker L
    Med Welt; 1968 Jul; 30():1684-5. PubMed ID: 5718817
    [No Abstract]   [Full Text] [Related]  

  • 32. [Action on the arterial pressure of a new antihypertensive agent (LD 3598) injected by the intramuscular route].
    Lagrue G; Giudicelli R; Boccon-Gibod L; Milliez P
    Presse Med (1893); 1966 Nov; 74(49):2535-6. PubMed ID: 5920840
    [No Abstract]   [Full Text] [Related]  

  • 33. [A clinical trial of guanoxabenz: a hypotensive agent with central and hypertensive action (author's transl)].
    Ledoux F; Welsch M; Steimer C; Schwartz J
    Therapie; 1981; 36(2):187-91. PubMed ID: 7027519
    [No Abstract]   [Full Text] [Related]  

  • 34. Further observations on a new antihypertensive Vatensol (Compound 1029).
    Srivastava BN; Vyas GP; Tiwari AK; Tapa RS; Nema HS
    Indian Heart J; 1967 Oct; 19(4):329-35. PubMed ID: 4870899
    [No Abstract]   [Full Text] [Related]  

  • 35. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG; Bloxham CA; Walker JM
    Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experimentation with a new imidazoline derivative (ST155) in the treatment of arterial hypertension].
    Ferreira EB; Eichemberg R; Berlitz MF
    Hospital (Rio J); 1969 Jun; 75(6):2139-51. PubMed ID: 5311472
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
    Rosenthal J; Jäger H
    MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on the effect of Guanutil in the stationary treatment of arterial hypertension].
    Schnabel W
    Dtsch Gesundheitsw; 1971 Aug; 26(32):1507-11. PubMed ID: 5114582
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and statistical considerations on a new drug in the therapy of arterial hypertension. Controlled study].
    Antognetti R; Giovine GG
    Minerva Cardioangiol; 1984 May; 32(5):313-23. PubMed ID: 6382056
    [No Abstract]   [Full Text] [Related]  

  • 40. Guanadrel (Hylorel)--a new antihypertensive drug.
    Med Lett Drugs Ther; 1983 Oct; 25(646):95-6. PubMed ID: 6621504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.